Wilson's Disease

Ronald F. Pfeiffer

doi:10.1055/s-2007-971173

Seminars in Neurology, Inhaltsverzeichnis

Semin Neurol 2007; 27(2): 123-132
DOI: 10.1055/s-2007-971173

Wilson's Disease

Ronald F. Pfeiffer¹

¹Department of Neurology, University of Tennessee Health Science Center, Memphis, Tennessee

Abstract

ABSTRACT

Wilson's disease is an autosomal-recessive disorder caused by mutation in the ATP7B gene, with resultant impairment of biliary excretion of copper. Subsequent copper accumulation, first in the liver but ultimately in the brain and other tissues, produces protean clinical manifestations that may include hepatic, neurological, psychiatric, ophthalmological, and other derangements. Genetic testing is impractical because of the multitude of mutations that have been identified, so accurate diagnosis relies on judicious use of a battery of laboratory and other diagnostic tests. Lifelong palliative treatment with a growing stable of medications, or with liver transplantation if needed, can successfully ameliorate or prevent the progressive deterioration and eventual death that would otherwise inevitably ensue. This article discusses the epidemiology, genetics, pathophysiology, clinical features, diagnostic testing, and treatment of Wilson's disease.

KEYWORDS

Ceruloplasmin - copper - Wilson's disease - penicillamine - zinc

Volltext

Referenzen

REFERENCES

1 Walshe J M. History of Wilson's disease: 1912 to 2000. Mov Disord. 2006; 21 142-147
2 Wilson S AK. Progressive lenticular degeneration: a familial nervous disease associated with cirrhosis of the liver. Brain. 1912; 34 295-507
3 Kayser B. Uber einen Fall von angeborener grünlicher Verfärbung der Kornea. Klin Monatsbl Augenheilkd. 1902; 40 22-25
4 Fleischer B. Zwei weiterer Falle von grünlicher Verfärbung der Kornea. Klin Monatsbl Augenheilkd. 1903; 41 489-491
5 Fleischer B. Uber eine der “Pseudosklerose” nahestehende, bisher unbekannte Krankheit (gekennzeichnet durch tremor, psychische storungen, braunliche Pigmentierung bestimmter gewebe, inbesondere auch der Hornhautperipherie, Lebercirrhose). Dtsch Z Nervenheilkd. 1912; 44 179-201
6 Rumpel A. Über das Wesen und die Bedeutung der Leberveränderungen und der Pigmentierunen bei den damit verbundenen Fällen von Psuedosklerose, zugleich ein Beitrag zur Lehre von der Pseudosklerose (Westphal-Strümpell). Dtsch Z Nervenheilkd. 1913; 49 54-73
7 Mandelbrote B M, Stanier M W, Thompson R HS, Thurston M N. Studies on copper metabolism in demyelinating diseases of the central nervous system. Brain. 1948; 71 212-228
8 Cumings J N. The copper and iron content of brain and liver in the normal and in hepato-lenticular degeneration. Brain. 1948; 71 410-415
9 Scheinberg I H, Gitlin D. Deficiency of ceruloplasmin in patients with hepatolenticular degeneration (Wilson's disease). Science. 1952; 116 484-485
10 Bearn A G, Kunkel H G. Biochemical abnormalities in Wilson's disease. J Clin Invest. 1952; 31 616
11 Frommer D J. Defective biliary excretion of copper in Wilson's disease. Gut. 1974; 15 125-129
12 Saito T. An assessment of efficiency in potential screening for Wilson's disease. J Epidemiol Community Health. 1981; 35 274-280
13 Scheinberg I H, Sternlieb I. Wilson's Disease. Philadelphia; WB Saunders 1984
14 Brewer G J. Wilson's Disease: A Clinician's Guide to Recognition, Diagnosis, and Management. Boston; Kluwer Academic Publishers 2001
15 Olivarez L, Caggana M, Pass K A, Ferguson P, Brewer G J. Estimate of the frequency of Wilson's disease in the US Caucasian population: a mutation analysis approach. Ann Hum Genet. 2001; 65 459-463
16 Bull P C, Thomas G R, Rommens J M, Forbes J R, Cox D W. The Wilson disease gene is a putative copper transporting P-type ATPase similar to the Menkes gene. Nat Genet. 1993; 5 327-337
17 Petrukhin K, Fischer S G, Piratsu M et al.. Mapping, cloning and genetic characterization of the region containing the Wilson disease gene. Nat Genet. 1993; 5 338-343
18 Yamaguchi Y, Heiny M E, Gitlin J D. Isolation and characterization of a human liver cDNA as a candidate gene for Wilson disease. Biochem Biophys Res Commun. 1993; 197 271-277
19 Petrukhin K, Lutsenko S, Chernov I, Ross B M, Kaplan J H, Gilliam T C. Characterization of the Wilson disease gene encoding a P-type copper transporting ATPase: genomic organization, alternative splicing, and structure/function predictions. Hum Mol Genet. 1994; 3 1647-1656
20 Cox D W, Prat L, Walshe J M, Heathcote J, Gaffney D. Twenty-four novel mutations in Wilson disease patients of predominantly European ancestry. Hum Mutat. 2005; 26 280-286
21 Loudianos G, Lovicu M, Dessi V et al.. Abnormal mRNA splicing resulting from consensus sequence splicing mutations of ATP7B. Hum Mutat. 2002; 20 260-266
22 Gromadzka G, Schmidt H H, Genschel J et al.. p.H1069Q mutation in ATP7B and biochemical parameters of copper metabolism and clinical manifestation of Wilson's disease. Mov Disord. 2006; 21 245-248
23 Vrabelova S, Letocha O, Borsky M, Kozak L. Mutation analysis of the ATP7B gene and genotype/phenotype correlation in 227 patients with Wilson disease. Mol Genet Metab. 2005; 86 277-285
24 Gromadzka G, Schmidt H H-J, Genschel J et al.. Frameshift and nonsense mutations in the gene for ATPase7B are associated with severe impairment of copper metabolism and with an early clinical manifestation of Wilson's disease. Clin Genet. 2005; 68 524-532
25 Senzolo M, Loreno M, Fagiuoli S et al.. Different neurological outcome of liver transplantation for Wilson's disease in two homozygotic twins. Clin Neurol Neurosurg. 2007; 109 71-75
26 Grubenbecher S, Stüve O, Hefter H, Korth C. Prion protein gene codon 129 modulates clinical course of neurological Wilson disease. Neuroreport. 2006; 17 549-552
27 Merle U, Stremmel W, Gessner R. Influence of homozygosity for methionine at codon 129 of the human prion gene on the onset of neurological and hepatic symptoms in Wilson disease. Arch Neurol. 2006; 63 982-985
28 Sechi G, Antonio Cocco G A, Errigo A et al.. Three sisters with very-late-onset major depression and parkinsonism. Parkinsonism Relat Disord. 2006; May 29; , (Epub ahead of print)
29 Hung I H, Suzuki M, Yamaguchi Y, Yuan D S, Klausner R D, Gitlin J D. Biochemical characterization of the Wilson disease protein and functional expression in the yeast Saccharomyces cerevisiae . J Biol Chem. 1997; 272 21461-21466
30 La Fontaine S, Theophilos M B, Firth S D, Gould R, Parton R G, Mercer J F. Effect of the toxic milk mutation (tx) on the function and intracellular localization of Wnd, the murine homologue of the Wilson copper ATPase. Hum Mol Genet. 2001; 10 361-370
31 Forbes J R, Cox D W. Copper-dependent trafficking of Wilson disease mutant ATP7B proteins. Hum Mol Genet. 2000; 9 1927-1935
32 Mufti A R, Burstein E, Csomos R A et al.. XIAP is a copper binding protein deregulated in Wilson's disease and other copper toxicosis disorders. Mol Cell. 2006; 21 775-785
33 Gibbs K, Walshe M. A study of the ceruloplasmin concentrations found in 75 patients with Wilson's disease, their kinships and various control groups. Q J Med. 1979; 48 447-463
34 Walshe J M. Wilson's disease: the presenting symptoms. Arch Dis Child. 1962; 37 253-256
35 Walshe J M. Wilson's disease (HLD). In: Vinken PJ, Bruyn GW Handbook of Clinical Neurology. Vol. 27. Amsterdam; North Holland Publishing Company 1976: 379-414
36 Beyersdorff A, Findeisen A. Morbus Wilson: case report of a two-year-old child as first manifestation. Scand J Gastroenterol. 2006; 41 496-497
37 Gow P J, Smallwood R A, Angus P W, Smith A L, Wall A J, Sewell R B. Diagnosis of Wilson's disease: an experience over three decades. Gut. 2000; 46 415-419
38 Sternlieb I, Scheinberg I H. Chronic hepatitis as a first manifestation of Wilson's disease. Ann Intern Med. 1972; 76 59-64
39 Scott J, Gollan J L, Samourian S, Sherlock S. Wilson's disease presenting as chronic active hepatitis. Gastroenterology. 1978; 74 645-651
40 Schilsky M L, Fink S. Inherited metabolic liver disease. Curr Opin Gastroenterol. 2006; 22 215-222
41 Schilsky M L, Scheinberg I H, Sternlieb I. Liver transplantation for Wilson's disease: indications and outcome. Hepatology. 1994; 19 583-587
42 Roche-Sicot J, Benhamou J P. Acute intravascular hemolysis and acute liver failure associated as a first manifestation of Wilson's disease. Ann Intern Med. 1977; 86 301-303
43 Strickland G T, Leu M L. Wilson's disease: clinical and laboratory manifestations in 40 patients. Medicine. 1975; 54 113-137
44 Ala A, Borjigin J, Rochwarger A, Schilsky M. Wilson disease in septuagenarian siblings: raising the bar for diagnosis. Hepatology. 2005; 41 668-670
45 Hellman N E, Gitlin J D. Ceruloplasmin metabolism and function. Annu Rev Nutr. 2002; 22 439-458
46 Parker N. Hereditary whispering dysphonia. J Neurol Neurosurg Psychiatry. 1985; 48 218-224
47 Cartwright G E. Diagnosis of treatable Wilson's disease. N Engl J Med. 1978; 298 1347-1350
48 Walshe J M, Yealland M. Wilson's disease: the problem of delayed diagnosis. J Neurol Neurosurg Psychiatry. 1992; 55 692-696
49 Svetel M, Kozic D, Stefanova E, Semnic R, Dragasevic N, Kostic V S. Dystonia in Wilson's disease. Mov Disord. 2001; 16 719-723
50 Barbosa E R, Silveira-Moriyama L, Machado A C, Bacheschi L A, Rosemberg S, Scaff M. Wilson's disease with myoclonus and white matter lesions. Parkinsonism Relat Disord. 2006; May 30; (Epub ahead of print)
51 Papapetropoulos S, Singer C. Painless legs moving toes in a patient with Wilson's disease. Mov Disord. 2006; 21 579-580
52 Bhattacharya K, Velickovic M, Schilsky M, Kaufmann H. Autonomic cardiovascular reflexes in Wilson's disease. Clin Auton Res. 2002; 12 190-192
53 Meenakshi-Sundaram S, Taly A B, Kamath V, Arunodaya G R, Rao S, Swamy H S. Autonomic dysfunction in Wilson's disease: a clinical and electrophysiological study. Clin Auton Res. 2002; 12 185-189
54 Dening T R, Berrios G E, Walshe J M. Wilson's disease and epilepsy. Brain. 1988; 111 1139-1155
55 Polychronopoulos P, Argyriou A A, Papapetropoulos S, Gourzis P, Rigas G, Chroni E. Wilson's disease and benign epilepsy of childhood with centrotemporal (rolandic) spikes. Epilepsy Behav. 2006; 8 438-441
56 Kumar S. Wilson's disease presenting as status epilepticus. Indian Pediatr. 2005; 42 492-493
57 Jung K H, Ahn T B, Jeon B S. Wilson disease with an initial manifestation of polyneuropathy. Arch Neurol. 2005; 62 1628-1631
58 Mueller A, Reuner U, Landis B, Kitzler H, Reichmann H, Hummel T. Extrapyramidal symptoms in Wilson's disease are associated with olfactory dysfunction. Mov Disord. 2006; 21 1311-1316
59 Akil M, Schwartz J A, Dutchak D, Yuzbasiyan-Gurkan V, Brewer G J. The psychiatric presentations of Wilson's disease. J Neuropsychiatry Clin Neurosci. 1991; 3 377-382
60 Brewer G J. Behavioral abnormalities in Wilson's disease. Adv Neurol. 2005; 96 262-274
61 Oder W, Grimm G, Kollegger H, Ferenci P, Schneider B, Deecke L. Neurological and neuropsychiatric spectrum of Wilson's disease: a prospective study of 45 cases. J Neurol. 1991; 238 281-287
62 Dening T R. Psychiatric aspects of Wilson's disease. Br J Psychiatry. 1985; 147 677-682
63 Kaul A, McMahon D. Wilson's disease and offending behavior: a case report. Med Sci Law. 1993; 33 353-358
64 Seniow J, Bak T, Gajda J, Poniatowska R, Czlonkowska A. Cognitive functioning in neurologically symptomatic and asymptomatic forms of Wilson's disease. Mov Disord. 2002; 17 1077-1083
65 Portala K, Levander S, Westermark K, Ekselius L, von Knorring L. Pattern of neuropsychological deficits in patients with treated Wilson's disease. Eur Arch Psychiatry Clin Neurosci. 2001; 251 262-268
66 Gronlund J, Nanto-Salonen K, Venetoklis J, Holmberg R L, Heinonen A, Stahlberg M R. Poor cognitive development and abdominal pain: Wilson's disease. Scand J Gastroenterol. 2006; 41 361-364
67 Brewer G J. Recognition, diagnosis, and management of Wilson's disease. Proc Soc Exp Biol Med. 2000; 223 39-46
68 Wiebers D O, Hollenhorst R W, Goldstein N P. The ophthalmologic manifestations of Wilson's disease. Mayo Clin Proc. 1977; 52 409-416
69 Johnson R E, Campbell R J. Wilson's disease: electron microscopic, x-ray energy spectroscopic, and atomic absorption spectroscopic studies of corneal copper deposition and distribution. Lab Invest. 1982; 46 564-569
70 Innes J R, Strachan I M, Triger D R. Unilateral Kayser-Fleischer ring. Br J Ophthalmol. 1986; 70 469-470
71 Sussman W, Scheinberg I H. Disappearance of Kayser-Fleischer rings: effects of penicillamine. Arch Ophthalmol. 1969; 82 738-741
72 Ross M E, Jacobson I M, Dienstag D L, Martin J B. Late onset Wilson's disease with neurological involvement in the absence of Kayser-Fleischer rings. Ann Neurol. 1985; 17 411-413
73 Pfeiffer R F. Wilson's disease. In: Watts RL, Koller WC Movement Disorders. Neurologic Principles and Practice. New York; McGraw-Hill Medical Publishers 2004: 779-797
74 Siemerling E, Oloff H. Pseudosklerose (Westphal-Strümpell) mit Cornealring (Kayser-Fleischer) und doppelseitiger Scheinkatarakt, die nur bei seitlicher Beleuchtnung sichtbar ist und die der nach Verletzung durch Kupfersplitter entstehenden Katarakt änlich ist. Klin Wochenschr. 1922; 1 1087-1089
75 Cairns J E, Williams H P, Walshe J M. “Sunflower cataract” in Wilson's disease. Br Med J. 1969; 3 95-96
76 Golding D N, Walshe J M. Arthropathy of Wilson's disease: study of clinical and radiological features in 32 patients. Ann Rheum Dis. 1977; 36 99-111
77 Canelas H M, Carvalho N, Scaff M, Vitule A, Barbosa E R, Azevedo E M. Osteoarthropathy of hepatolenticular degeneration. Acta Neurol Scand. 1978; 57 481-487
78 Mindelzun R, Elkin M, Scheinberg I H, Sternlieb I. Skeletal changes in Wilson's disease: a radiological study. Radiology. 1970; 94 127-132
79 Yarze J C, Martin P, Munoz S J, Friedman L S. Wilson's disease: current status. Am J Med. 1992; 92 643-654
80 McIntyre N, Clink H M, Levi A J, Cumings J N, Sherlock S. Hemolytic anemia in Wilson's disease. N Engl J Med. 1967; 276 439-444
81 Sternlieb I. Wilson's disease: indications for liver transplants. Hepatology. 1984; 4 15S-17S
82 Donfrid M, Jankovic G, Strahinja R, Colovic R, Begic-Janeva A, Colovic M. Idiopathic thrombocytopenia associated with Wilson's disease. Hepatogastroenterology. 1998; 45 1774-1776
83 Atanassova P A, Panchovska M S, Tzvetanov P, Chalakova N T, Masaldzhieva R I, Dimitrov B D. Hepatolenticular degeneration combined with primary antiphospholipid syndrome: a case report. Eur Neurol. 2006; 55 42-43
84 Wiebers D O, Wilson D M, McLeod R A, Goldstein N P. Renal stones in Wilson's disease. Am J Med. 1979; 67 249-254
85 Narayanan P, Chetan G, Mahadevan S. Wilson's disease presenting as respiratory failure. Indian J Pediatr. 2006; 73 99-100
86 Leu M L, Strickland G T, Wang C C, Chen T S. Skin pigmentation in Wilson's disease. JAMA. 1970; 211 1542-1543
87 Scheinberg I H, Sternlieb I. Wilson's disease. Annu Rev Med. 1965; 16 119-134
88 Lau J Y, Lai C L, Wu P C, Pan H Y, Lin H J, Todd D. Wilson's disease: 35 years' experience. Q J Med. 1990; 75 597-605
89 Ferenci P, Steindl-Munda P, Vogel W et al.. Diagnostic value of quantitative hepatic copper determination in patients with Wilson's disease. Clin Gastroenterol Hepatol. 2005; 3 811-818
90 Smallwood R A, Williams H A, Rosenoer V M, Sherlock S. Liver-copper levels in liver disease: studies using neutron activation analysis. Lancet. 1968; 2 1310-1313
91 Benson G D. Hepatic copper accumulation in primary biliary cirrhosis. Yale J Biol Med. 1979; 52 83-88
92 Willeit J, Kiechl S G. Wilson's disease with neurologic impairment but no Kayser-Fleischer rings. Lancet. 1991; 337 1426
93 Oracz G, Klimczak-Slaczka D, Sokolowska-Oracz A et al.. [Prevalence of Kayser-Fleischer ring in patients with Wilson's disease]. [In Polish]. Klin Oczna. 2005; 107 54-56
94 Das S K, Ray K. Wilson's disease: an update. Nat Clin Pract Neurol. 2006; 2 482-493
95 Sinha S, Taly A B, Ravishankar S et al.. Wilson's disease: cranial MRI observations and clinical correlation. Neuroradiology. 2006; 48 613-621
96 Walter U, Krolikowski K, Tarnacka B, Benecke R, Czlonkowska A, Dressler D. Sonographic detection of basal ganglia lesions in asymptomatic and symptomatic Wilson disease. Neurology. 2005; 64 1726-1732
97 Hartard C, Weisner B, Dieu C, Kunze K. Wilson's disease with cerebral manifestation: monitoring therapy by CSF copper concentration. J Neurol. 1993; 241 101-107
98 Hoogenraad T U. Paradigm shift in the treatment of Wilson's disease: zinc therapy now treatment of choice. Brain Dev. 2006; 28 141-146
99 Walshe J M. Penicillamine, a new oral therapy for Wilson's disease. Am J Med. 1956; 21 487-495
100 Brewer G J, Askari F, Lorincz M T et al.. Treatment of Wilson disease with ammonium tetrathiomolybdate. Arch Neurol. 2006; 63 521-527
101 Walshe J M, Yealland M. Chelation treatment of neurological Wilson's disease. Q J Med. 1993; 86 197-204
102 Brewer G J, Terry C A, Aisen A M, Hill G M. Worsening of neurologic syndrome in patients with Wilson's disease with initial penicillamine therapy. Arch Neurol. 1987; 44 490-493
103 Prashanth L K, Taly A B, Sinha S et al.. Prognostic factors in patients presenting with severe neurological forms of Wilson's disease. QJM. 2005; 98 557-563
104 Sternlieb I, Scheinberg I H. Penicillamine therapy for hepatolenticular degeneration. JAMA. 1964; 189 748-754
105 Haggstrom G D, Hirschowitz B I, Flint A. Long-term penicillamine therapy for Wilson's disease. South Med J. 1980; 73 530-531
106 Sternlieb I, Fisher M, Scheinberg I H. Penicillamine-induced skin lesions. J Rheumatol Suppl. 1981; 7 149-154
107 Walshe J M. Penicillamine: the treatment of first choice for patients with Wilson's disease. Mov Disord. 1999; 14 545-550
108 Schafer D F, Shaw Jr B W. Fulminant hepatic failure and orthotopic liver transplantation. Semin Liver Dis. 1989; 9 189-194
109 Medici V, Mirante V G, Fassati L R et al.. Liver transplantation for Wilson's disease: the burden of neurological and psychiatric disorders. Liver Transpl. 2005; 11 1056-1063
110 Wang X H, Cheng F, Zhang F et al.. Living-related liver transplantation for Wilson's disease. Transpl Int. 2005; 18 651-656
111 Tamura S, Sugawara Y, Kishi Y, Akamatsu N, Kaneko J, Makuuchi M. Living-related liver transplantation for Wilson's disease. Clin Transplant. 2005; 19 483-486

Ronald F PfeifferM.D.

Professor and Vice Chair, Department of Neurology, University of Tennessee Health Science Center

855 Monroe Avenue, Memphis, TN 38163